Home » Topics » Regulatory » Patents

Patents
RSS

Bristol-Myers Squibb continues to search for new ET antagonists

Sep. 27, 1996

Quinoline LTD4/LTE4 inhibitors from Ciba-Geigy

Sep. 27, 1996

E. Merck reports PDE IV inhibitors

Sep. 27, 1996

Sagami prepares NGF production-enhancing compounds

Sep. 27, 1996

Natural cerebral function-improving agents from Yamanouchi

Sep. 27, 1996

Neurite outgrowth inducers presented by Kitasato Institute

Sep. 27, 1996

Egis claims new anxiolytics with a favorable side effect profile

Sep. 27, 1996

Novel MAb reported by Kyowa Hakko

Sep. 27, 1996

Lilly's antiobesity proteins

Sep. 27, 1996

Takeda reports new agent for improving lipid metabolism

Sep. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....